col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: Antiviral Research
  original article Date Title Authors   All Authors
1 [GO] 2021―Nov―24 Hydroxychloroquine and azithromycin used alone or combined are not effective against SARS-CoV-2 ex vivo and in a hamster model Maxime Cochin, Franck Touret, Jean-Sélim Driouich, Gregory Moureau, Paul-Rémi Petit, Caroline Laprie, et al. (+3)
2 [GO] 2021―Nov―18 2-((1H-indol-3-yl)thio)-N-phenyl-acetamides: SARS-CoV-2 RNA-dependent RNA polymerase inhibitors Jianyuan Zhao, Guoning Zhang, Yongxin Zhang, Dongrong Yi, Quanjie Li, Ling Ma, et al. (+8)
3 [GO] 2021―Nov―10 Picomolar inhibition of SARS-CoV-2 variants of concern by an engineered ACE2-IgG4-Fc fusion protein Hristo L. Svilenov, Julia Sacherl, Alwin Reiter, Lisa S. Wolff, Cho-Chin Cheng, Marcel Stern, et al. (+10)
4 [GO] 2021―Nov―08 Development and characterization of SARS-CoV-2 variant-neutralizing monoclonal antibodies Hongyu Qiu, Xin-Yong Yuan, Teresa Cabral, Kathy Manguiat, Alyssia Robinson, Heidi Wood, et al. (+8)
5 [GO] 2021―Oct―21 Inhibition of endocytosis of porcine reproductive and respiratory syndrome virus by rottlerin and its potential prophylactic administration in piglets Yeong-Lim Kang, Changin Oh, So-Hyun Ahn, Jong-Chul Choi, Hwi-Yeon Choi, Sang-Won Lee, et al. (+4)
6 [GO] 2021―Oct―08 SARS-CoV-2 monoclonal antibodies with therapeutic potential: Broad neutralizing activity and No evidence of antibody-dependent enhancement Ying-Ting Wang, Robert D. Allen, Kenneth Kim, Norazizah Shafee, Andrew J. Gonzalez, Michael N. Nguyen, et al. (+9)
7 [GO] 2021―Oct―07 A fluorescence-based, gain-of-signal, live cell system to evaluate SARS-CoV-2 main protease inhibition Rama Dey-Rao, George R. Smith, Uddhav Timilsina, Zackary Falls, Ram Samudrala, Spyridon Stavrou, Thomas Melendy
8 [GO] 2021―Aug―24 Identification of Niemann-Pick C1 protein as a potential novel SARS-CoV-2 intracellular target Isabel García-Dorival, Miguel Ángel Cuesta-Geijo, Lucía Barrado-Gil, Inmaculada Galindo, Urtzi Garaigorta, Jesús Urquiza, et al. (+6)
9 [GO] 2021―Aug―09 Polyphenylene carboxymethylene (PPCM) microbicide repurposed as antiviral against SARS-CoV-2. Proof of concept in primary human undifferentiated epithelial cells Olivier Escaffre, Alexander N. Freiberg
10 [GO] 2021―Aug―08 A tetrameric ACE2 protein broadly neutralizes SARS-CoV-2 spike variants of concern with elevated potency Adam Leach, F. Tudor Ilca, Zulaikha Akbar, Mathieu Ferrari, Emma M. Bentley, Giada Mattiuzzo, et al. (+4)
11 [GO] 2021―Jul―23 Identification and evaluation of potential SARS-CoV-2 antiviral agents targeting mRNA cap guanine N7-Methyltransferase Renata Kasprzyk, Tomasz J. Spiewla, Miroslaw Smietanski, Sebastian Golojuch, Laura Vangeel, Steven De Jonghe, et al. (+4)
12 [GO] 2021―Jul―12 Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2 Franck Touret, Jean-Sélim Driouich, Maxime Cochin, Paul Rémi Petit, Magali Gilles, Karine Barthélémy, et al. (+6)
13 [GO] 2021―Jul―08 A mouse model of lethal respiratory dysfunction for SARS-CoV-2 infection Esther S. Gan, Ayesa Syenina, Martin Linster, Benson Ng, Summer L. Zhang, Satoru Watanabe, et al. (+4)
14 [GO] 2021―Jun―26 A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agents Thuc Nguyen Dan Do, Kim Donckers, Laura Vangeel, Arnab K. Chatterjee, Philippe A. Gallay, Michael D. Bobardt, et al. (+5)
15 [GO] 2021―Jun―19 Selinexor, a novel selective inhibitor of nuclear export, reduces SARS-CoV-2 infection and protects the respiratory system in vivo Trinayan Kashyap, Jackelyn Murray, Christopher J. Walker, Hua Chang, Sharon Tamir, Bing Hou, et al. (+4)
16 [GO] 2021―May―16 Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro Jeremy R.A. Paull, Graham P. Heery, Michael D. Bobardt, Alex Castellarnau, Carolyn A. Luscombe, Jacinth K. Fairley, Philippe A. Gallay
17 [GO] 2021―Apr―21 A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymerase Jianyuan Zhao, SaiSai Guo, Dongrong Yi, Quanjie Li, Ling Ma, Yongxin Zhang, et al. (+7)
18 [GO] 2021―Apr―17 Discovery of Chebulagic Acid and Punicalagin as Novel Allosteric Inhibitors of SARS-CoV-2 3CLpro Ruikun Du, Laura Cooper, Zinuo Chen, Hyun Lee, Lijun Rong, Qinghua Cui
19 [GO] 2021―Mar―27 Proteomic Analysis Identifies the RNA Helicase DDX3X as a Host Target Against SARS-CoV-2 Infection Fabiola Ciccosanti, Martina Di Rienzo, Alessandra Romagnoli, Francesca Colavita, Giulia Refolo, Concetta Castilletti, et al. (+8)
20 [GO] 2021―Mar―11 Emetine suppresses SARS-CoV-2 replication by inhibiting interaction of viral mRNA with eIF4E Ram Kumar, Mohammad Afsar, Nitin Khandelwal, Yogesh Chander, Thachamvally Riyesh, Ramesh Kumar Dedar, et al. (+6)
21 [GO] 2021―Mar―11 Combined in silico and in vitro approaches identified the antipsychotic drug lurasidone and the antiviral drug elbasvir as SARS-CoV2 and HCoV-OC43 inhibitors Mario Milani, Manuela Donalisio, Rafaela Milan Bonotto, Edoardo Schneider, Irene Arduino, Francesco Boni, et al. (+3)
22 [GO] 2021―Feb―06 Genetic Conservation of SARS-CoV-2 RNA Replication Complex in Globally Circulating Isolates and Recently Emerged Variants from Humans and Minks Suggests Minimal Pre-Existing Resistance to Remdesivir Ross Martin, Jiani Li, Aiyippa Parvangada, Jason Perry, Tomas Cihlar, Hongmei Mo, et al. (+2)
23 [GO] 2021―Jan―27 Dual Inhibition of SARS-CoV-2 and Human Rhinovirus with Protease Inhibitors in Clinical Development Cheng Liu, Sandro Boland, Michael D. Scholle, Dorothee Bardiot, Arnaud Marchand, Patrick Chaltin, et al. (+7)
24 [GO] 2021―Jan―13 Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system Qingyuan Zhu, Yaling Zhang, Li Wang, Xiangyu Yao, Daitze Wu, Junjun Cheng, et al. (+4)
25 [GO] 2021―Jan―08 The rocaglate CR-31-B (-) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in vitro and ex vivo Christin Müller, Wiebke Obermann, Nadja Karl, Hans-Guido Wendel, Gaspar Taroncher-Oldenburg, Stephan Pleschka, et al. (+3)
26 [GO] 2020―Dec―10 Antiviral activity against Middle East Respiratory Syndrome Coronavirus by Montelukast, an anti-asthma drug Hanjie Jonathan Gan, Amaravadhi Harikishore, Jihye Lee, Sangeun Jeon, Sreekanth Rajan, Ming Wei Chen, et al. (+3)
27 [GO] 2020―Nov―25 Ionophore antibiotic X-206 is a potent inhibitor of SARS-CoV-2 infection in vitro Esben B. Svenningsen, Jacob Thyrsted, Julia Blay-Cadanet, Han Liu, Shaoquan Lin, Jaime Moyano Villameriel, et al. (+5)
28 [GO] 2020―Nov―17 A bacterial artificial chromosome (BAC)-vectored noninfectious replicon of SARS-CoV-2 Yang Zhang, Wuhui Song, Shuiye Chen, Zhenghong Yuan, Zhigang Yi
29 [GO] 2020―Oct―19 Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes Seong Woo Choi, Jin Soo Shin, Soon-Jung Park, Eunhye Jung, Yun-Gwi Park, Jiho Lee, et al. (+7)
30 [GO] 2020―Sep―19 Cryptotanshinone Protects Porcine Alveolar Macrophages from Infection with Porcine Reproductive and Respiratory Syndrome Virus Chang Huang, Jiaqi Zhu, Ling Wang, Alexander Chu, Yexuan Yin, Kaneha Vali, et al. (+2)
31 [GO] 2020―Sep―07 Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses Sirin Theerawatanasirikul, Chih Jung Kuo, Nanthawan Phecharat, Jullada Chootip, Chalermpol Lekcharoensuk, Porntippa Lekcharoensuk
32 [GO] 2020―Sep―06 Evaluation of SARS-CoV-2 3C-like protease inhibitors using self-assembled monolayer desorption ionization mass spectrometry Zachary A. Gurard-Levin, Cheng Liu, Andreas Jekle, Ruchika Jaisinghani, Suping Ren, Koen Vandyck, et al. (+9)
33 [GO] 2020―Jul―30 The chemokine receptor antagonist cenicriviroc inhibits the replication of SARS-CoV-2 in vitro Mika Okamoto, Masaaki Toyama, Masanori Baba
34 [GO] 2020―Jul―29 An enzyme-based immunodetection assay to quantify SARS-CoV-2 infection Carina Conzelmann, Andrea Gilg, Rüdiger Groß, Desiree Schütz, Nico Preising, Ludger Ständker, et al. (+7)
35 [GO] 2020―Jul―15 In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2 Andrés Pizzorno, Blandine Padey, Julia Dubois, Thomas Julien, Aurélien Traversier, Victoria Dulière, et al. (+4)
36 [GO] 2020―Jul―15 Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors Pierre Gallian, Boris Pastorino, Pascal Morel, Jacques Chiaroni, Laetitia Ninove, Xavier de Lamballerie
37 [GO] 2020―Jul―10 Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection Nicolas Venisse, Gilles Peytavin, Stephane Bouchet, Marie-Claude Gagnieu, Rodolphe Garraffo, Romain Guilhaumou, Caroline Solas
38 [GO] 2020―Jul―10 Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions So Young Kim, Weihua Jin, Amika Sood, David W. Montgomery, Oliver C. Grant, Mark M. Fuster, et al. (+5)
39 [GO] 2020―Jul―10 Immunoglobulin fragment F(ab’)2 against RBD potently neutralizes SARS-CoV-2 in vitro Xiaoyan Pan, Pengfei Zhou, Tiejiong Fan, Yan Wu, Jing Zhang, Xiaoyue Shi, et al. (+9)
40 [GO] 2020―Jun―19 The influence of interferon-lambda on restricting Middle East Respiratory Syndrome Coronavirus replication in the respiratory epithelium Yung Jin Jeon, Chan Hee Gil, Ara Jo, Jina Won, Sujin Kim, Hyun Jik Kim
41 [GO] 2020―Jun―18 A Library of Nucleotide Analogues Terminate RNA Synthesis Catalyzed by Polymerases of Coronaviruses that Cause SARS and COVID-19 Steffen Jockusch, Chuanjuan Tao, Xiaoxu Li, Thomas K. Anderson, Minchen Chien, Shiv Kumar, et al. (+3)
42 [GO] 2020―May―13 Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2 Wanbo Tai, Xiujuan Zhang, Yuxian He, Shibo Jiang, Lanying Du
43 [GO] 2020―Apr―29 Antiviral Activities of Type I Interferons to SARS-CoV-2 Infection Emily Mantlo, Natalya Bukreyeva, Junki Maruyama, Slobodan Paessler, Cheng Huang
44 [GO] 2020―Apr―21 Ivermectin and COVID-19: a report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses Mike Bray, Craig Rayner, François Noël, David Jans, Kylie Wagstaff
45 [GO] 2020―Apr―10 Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites Ashleigh Shannon, Nhung Thi-Tuyet Le, Barbara Selisko, Cecilia Eydoux, Karine Alvarez, Jean-Claude Guillemot, et al. (+4)
46 [GO] 2020―Apr―07 Type 1 interferons as a potential treatment against COVID-19 Erwan Sallard, François-Xavier Lescure, Yazdan Yazdanpanah, France Mentre, Nathan Peiffer-Smadja
47 [GO] 2020―Apr―06 Coronavirus membrane fusion mechanism offers as a potential target for antiviral development Tiffany Tang, Miya Bidon, Javier A. Jaimes, Gary R. Whittaker, Susan Daniel
48 [GO] 2020―Apr―03 The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro Leon Caly, Julian D. Druce, Mike G. Catton, David A. Jans, Kylie M. Wagstaff
49 [GO] 2020―Apr―03 Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro Ka-Tim Choy, Alvina Yin-Lam Wong, Prathanporn Kaewpreedee, Sin-Fun Sia, Dongdong Chen, Kenrie Pui Yan Hui, et al. (+6)
50 [GO] 2020―Mar―06 Of chloroquine and COVID-19 Franck Touret, Xavier de Lamballerie
51 [GO] 2020―Mar―01 A potential role for integrins in host cell entry by SARS-CoV-2 Christian JA Sigrist, Alan Bridge, Philippe Le Mercier
52 [GO] 2020―Feb―27 Efficacy of anti-influenza immunoglobulin (FLU-IGIV) in ferrets and mice infected with 2009 pandemic influenza virus Hongyu Qiu, Hanne Andersen, E. Bart Tarbet, F. Salih Muhammad, Trevor Carnelley, Russell Pronyk, et al. (+2)
53 [GO] 2020―Feb―10 The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade B. Coutard, C. Valle, X. de Lamballerie, B. Canard, N.G. Seidah, E. Decroly


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.008 sec